Table 1.
Demographic, clinical, biochemical and hormonal characteristic of the study and control populations
| PCOS (n=55) | Controls (n=110) | P | |
|---|---|---|---|
| Demographic | |||
| Age (years) | 24.67±0.883 | 33.80±0.528 | 0.061 |
| Clinical | |||
| BMI (kg/m2) | 26.89±0.716 | 25.25±0.344 | 0.007 |
| mFG score | 8±0.445 | 3±0.222 | 0.006 |
| WC:HC | 0.839±0.008 | 0.824±0.004 | 0.114 |
| Biochemical/Hormonal | |||
| FBG (mg/dL) | 98.81±2.08 | 108.69±2.74 | 0.284 |
| Kisspeptin (nmol/L) | 4.873±0.238 | 4.127±0.132 | 0.033 |
| Testosterone (nmol/L) | 4.713±0.458 | 3.415±0.256 | 0.018 |
| TSH (µIU/mL) | 1.96±0.346 | Not done | - |
| FSH (mIU/mL) | 5.5±0.430 | Not done | - |
| LH (mIU/mL) | 7.34±1.198 | Not done | - |
PCOS: polycystic ovary syndrome, BMI: body mass index, mFG: modified Ferriman–Gallwey score, WC: HC: waist circumference: hip circumference, FBG: fasting blood glucose level, TSH: thyroid-stimulating hormone, FSH: follicle-stimulating hormone, LH: luteinizing hormone Data are given as mean±standard error of the mean